Breast Cancer Clinical Trial
Official title:
Reliability and Validity of Self-measured Arm Circumference in Women With Breast Cancer
Early detection and treatment of onset or worsening of breast cancer-related lymphedema (BCRL) can potentially prevent or postpone the condition to progress into a chronic progressive condition or eliminate the risk of infections in the arm (cellulitis). Self-surveillance for BCRL by routinely measuring own arm circumference could potentially enable early detection of onset or worsening of lymphedema. The aim is to determine whether women who have received surgery for breast cancer, can perform self-measures of arm circumference in a reliable and valid manner using written and video supported instructions without in-person teaching by a physiotherapist.
Purpose: to test the reliability and validity of self-measured arm circumference compared to
measures performed by a specialized therapist and by the perometer (gold standard).
The hypothesis is that there will be an excellent correlation between arm circumference
measures performed by the participant and by an experienced physiotherapist and a moderate
correlation between arm circumference measures performed by the patient and determined by
perometer, as well as arm volume calculated from arm circumference measurements and measured
by the perometer.
Design: A cross-sectional study of women at risk of breast cancer-related lymphedema (BCRL)
(n=20) and with BCRL (n=20)
Procedures: Participants will complete one self-assessment at home and one self-assessment at
a laboratory the University of British Columbia (UBC).
Home Self-assessment: Participants will be sent a study package by mail, which will contain
the consent form, a tape measure, written instructions supplemented with illustrations, a
link for a video guide, and a measurement form, along with an opaque envelop for the
measurement form. Participants will be asked to first review the written and video material
outlining the measurement process, prior to completing a short self-assessment quiz on the
self-measurement technique. Participants will then perform arm circumference measures of both
arms as per the instructions, record the measurements on the provided form and seal the form
in a provided envelope. The envelope will be returned to the study team at the lab
assessment.
Lab Self-assessment: At the visit at UBC, participants will be asked by study staff to repeat
these arm circumference measures with support from the video and written instructions,
unsupervised by a physiotherapist. This will be followed by an assessment by the
physiotherapist and measures with the perometer.
Statistical analysis plan: Intra-rater (between self-measures performed at home and at the
lab), inter-rater reliability (between self-measures performed at lab and therapist-measures)
and concurrent validity analysis (between self-measures performed at lab and perometer
measures) will be conducted separately for women with and without BCRL.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |